When it comes to the crunch – the swab test – planning and preparation are the key to the best performance.

The Chinese pharmaceutical market is already more advanced than many in the West imagine – and it only looks set to go in one direction.

As ever, our industry will have to deal with its fair share of sociopolitical “fun” in 2019. But what can we do?

Successes in the cell and gene therapy field show us that great advances can be made – without taking unnecessary risks.

Pharma manufacturers are not embracing patient-centric design when it comes to formulation. We need to go beyond tablets and capsules.

Sensory decline is a growing problem. When will pharma begin to see the light and address the problem once and for all?

If you or your supplier are working with animal-derived components, you run the risk of exposing patients to dangerous contaminations.

Struggling with process research and development? Find yourself a CRO that knows what it’s doing.

The color of a capsule or tablet can have a big impact on compliance and branding. To avoid delays, early decisions have to be made.

Regardless of how Britain leaves the European Union, the global pharma industry must always lobby for positive change.